Antitumor Effect of the KRAS G12C Inhibitor Sotorasib combined with Radiotherapy and Carboplatin/Cisplatin in human Lung Carcinoma Cell Lines

被引：0
|
作者：
Maltzahn, Christin [1 ]
Patties, Ina [1 ]
Kortmann, Rolf-Dieter [1 ]
Seidel, Clemens [1 ]
Glasow, Annegret [1 ]
机构：
[1] Univ Leipzig, Klin & Poliklin Strahlentherapie, Leipzig, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10-1
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [1] Synergism of KRAS G12C Inhibitor and mTOR Inhibitor in Lung Adenocarcinoma and Squamous Cell Carcinoma
    Ito, M.
    Miyata, Y.
    Hirano, S.
    Morihara, N.
    Irisuna, F.
    Takemoto, M.
    Tsutani, Y.
    Okada, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S429 - S429
  • [2] Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation
    Zheng, Xinting
    Luo, Jiamin
    Liu, Wei
    Ashby, Charles R., Jr.
    Chen, Zhe-Sheng
    Lin, Lizhu
    DRUGS OF TODAY, 2022, 58 (04) : 175 - 185
  • [3] Impact of a High-Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C Inhibitor
    Cardona, Panli
    Dutta, Sandeep
    Houk, Brett
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (11): : 1219 - 1226
  • [4] A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib
    Uruga, Hironori
    Miyamoto, Atsushi
    Fujii, Takeshi
    Okuma, Takashi
    Mitsumura, Takahiro
    Tamaoka, Meiyo
    Takazawa, Yutaka
    PATHOLOGY INTERNATIONAL, 2024, 74 (09) : 546 - 551
  • [5] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2022, 17 : 727 - 733
  • [6] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Lee, Arnold
    TARGETED ONCOLOGY, 2022, 17 (06) : 727 - 733
  • [7] Sotorasib in KRAS G12C-mutated non-small cell lung carcinoma
    Lorenz, Judith
    PNEUMOLOGIE, 2023, 77 (11): : 846 - 846
  • [8] Correction to: Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 : 177 - 177
  • [9] Addressing Atropisomerism in the Development of Sotorasib, a Covalent Inhibitor of KRAS G12C: Structural, Analytical, and Synthetic Considerations
    Lanman, Brian A.
    Parsons, Andrew T.
    Zech, Stephan G.
    ACCOUNTS OF CHEMICAL RESEARCH, 2022, 55 (20) : 2892 - 2903
  • [10] The MET Inhibitor Tepotinib Potentially Inhibits KRAS G12C and SHOC2 in KRAS G12C Non-Small Cell Lung Cancer (NSCLC)
    Rosell, R.
    Jain, A.
    Codony-Servat, J.
    Shivamallu, C.
    Kollur, S. Prasad
    Prasad, A.
    Jantus-Lewintre, E.
    Ito, M.
    Cardona, A. F.
    Arrieta, O.
    Cao, P.
    Cai, X.
    Xing, B.
    Pedraz-Valdunciel, C.
    Dantes, Z.
    Sullivan, I.
    Aguilar, A.
    Molina-Vila, M. A.
    Gonzalez-Cao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S112 - S112
12345